Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcus Biosciences (RCUS) Receivables - Net: 2017-2018

Historic Receivables - Net for Arcus Biosciences (RCUS) over the last 1 years, with Dec 2018 value amounting to $100,000.

  • Arcus Biosciences' Receivables - Net rose 300.00% to $100,000 in Q4 2018 from the same period last year, while for Dec 2018 it was $100,000, marking a year-over-year increase of 300.00%. This contributed to the annual value of $100,000 for FY2018, which is 300.00% up from last year.
  • Arcus Biosciences' Receivables - Net amounted to $100,000 in Q4 2018, which was down 0.00% from $100,000 recorded in Q3 2018.
  • Arcus Biosciences' Receivables - Net's 5-year high stood at $200,000 during Q2 2018, with a 5-year trough of $25,000 in Q4 2017.
  • Its 2-year average for Receivables - Net is $95,800, with a median of $100,000 in 2018.
  • Data for Arcus Biosciences' Receivables - Net shows a peak YoY surged of 300.00% (in 2018) over the last 5 years.
  • Over the past 2 years, Arcus Biosciences' Receivables - Net (Quarterly) stood at $25,000 in 2017, then soared by 300.00% to $100,000 in 2018.
  • Its Receivables - Net was $100,000 in Q4 2018, compared to $100,000 in Q3 2018 and $200,000 in Q2 2018.